managing side effects of semaglutide How Long Do Last? a Doctor's Guide Did you know about this

16.1%) Tirzepatide was superior on all five key secondary endpoints A post-hoc cardiovascular analysis published in European Heart Journal Open (September 2025) found tirzepatide was also associated with a greater predicted 10-year cardiovascular risk reduction an absolute reduction of 2.4% vs

Your clinician is reachable - not a chatbot

For patients in warmer climates, requesting expedited shipping during summer months is worth the additional cost

& Yachi, A

Small molecule programs remain high risk high reward Pfizers pullback from its own oral GLP-1 programs has highlighted a major scientific challenge: biased agonism can improve GI tolerability but does not eliminate hepatotoxicity risk

All GLP-1s are excellent medicines for diabetes and weight control